Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial

J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target

A promising Alzheimer’s treatment failed to slow the progress of the disease, news that could dampen enthusiasm for a new class of potential medicines. Read More

Analysts, investors not surprised by Novo's Alzheimer trial failure

Novo Nordisk said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet their main goal, sending shares of the Danish drugmaker down around 9% to ... Read More

Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ... Read More

Novo Nordisk's Alzheimer's trial a 'lottery ticket', senior executive says

COPENHAGEN, Sept 17 (Reuters) - A senior Novo Nordisk (NOVOb.CO), opens new tab executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for treatment of ... Read More

Novo Investors Eye Alzheimer’s Trial for Glimmer of Hope

After another dismal quarter for Novo Nordisk A/S shares, investors are looking to an experimental treatment of the most common form of dementia to help spark a revival. The Danish drugmaker is ... Read More

Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant

Pedersen COPENHAGEN (Reuters) -Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the progression of the brain-wasting disease, the ... Read More